Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Pinato

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Postgraduate Medicine|September 14, 2013
Imatinib induced pyoderma gangrenosumD J Pinato, R Sharma
Alimentary Pharmacology & Therapeutics|May 6, 2015
Editorial: dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma--authors' replyD J Pinato, R Sharma
Oncogene|October 6, 2015
TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibitionD J Pinato, S Chowdhury, J Stebbing
Alimentary Pharmacology & Therapeutics|December 12, 2017
Editorial: a step forward in refining prognostication for patients with HIV-associated hepatocellular carcinoma-Authors' replyD J Pinato, N Bräu, M Bower
British Journal of Cancer|March 22, 2012
A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)D J Pinato, B V North, R Sharma
Alimentary Pharmacology & Therapeutics|April 26, 2017
Review article: delivering precision oncology in intermediate-stage liver cancerD J Pinato, J Howell, R Ramaswami, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Systemic management of advanced HCC: an increasingly complex gameA Martirena, P Lombardi, D J Pinato, et al.
ESMO Open|May 1, 2021
The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancerG M Dettorre, M Patel, A Gennari, et al.
British Journal of Cancer|March 27, 2014
Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancerD J Pinato, R J Shiner, M J Seckl, et al.
British Journal of Cancer|January 31, 2013
The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesotheliomaD J Pinato, F A Mauri, T Lloyd, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Postgraduate Medicine|September 14, 2013
Imatinib induced pyoderma gangrenosumD J Pinato, R Sharma
Alimentary Pharmacology & Therapeutics|May 6, 2015
Editorial: dynamic changes of the inflammation-based index predict mortality following chemoembolisation for hepatocellular carcinoma--authors' replyD J Pinato, R Sharma
Oncogene|October 6, 2015
TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibitionD J Pinato, S Chowdhury, J Stebbing
Alimentary Pharmacology & Therapeutics|December 12, 2017
Editorial: a step forward in refining prognostication for patients with HIV-associated hepatocellular carcinoma-Authors' replyD J Pinato, N Bräu, M Bower
British Journal of Cancer|March 22, 2012
A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)D J Pinato, B V North, R Sharma
Alimentary Pharmacology & Therapeutics|April 26, 2017
Review article: delivering precision oncology in intermediate-stage liver cancerD J Pinato, J Howell, R Ramaswami, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Systemic management of advanced HCC: an increasingly complex gameA Martirena, P Lombardi, D J Pinato, et al.
ESMO Open|May 1, 2021
The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancerG M Dettorre, M Patel, A Gennari, et al.
British Journal of Cancer|March 27, 2014
Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancerD J Pinato, R J Shiner, M J Seckl, et al.
British Journal of Cancer|January 31, 2013
The expression of Axl receptor tyrosine kinase influences the tumour phenotype and clinical outcome of patients with malignant pleural mesotheliomaD J Pinato, F A Mauri, T Lloyd, et al.
Pageof 3